EndoSpan

1 known investors

Endospan develops endovascular stent graft systems, including the NEXUS Multi-Branch Aortic Arch Stent Graft System, for repairing aortic aneurysms and dissections in patients whose anatomy is unsuitable for traditional EVAR/TEVAR therapy. The company operates in the medical device sector, serving the endovascular aortic repair market.